Israel Antibody Discovery Market (2025-2031) | Consumer Insights, Supply, Segmentation, Strategy, Strategic Insights, Opportunities, Segments, Forecast, Competitive, Trends, Challenges, Value, Analysis, Companies, Share, Restraints, Revenue, Investment Trends, Pricing Analysis, Demand, Industry, Growth, Outlook, Competition, Size, Drivers

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Israel Country Macro Economic Indicators

3.2 Israel Antibody Discovery Market Revenues & Volume, 2021 & 2031F

3.3 Israel Antibody Discovery Market - Industry Life Cycle

3.4 Israel Antibody Discovery Market - Porter's Five Forces

3.5 Israel Antibody Discovery Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 Israel Antibody Discovery Market Revenues & Volume Share, By End User, 2021 & 2031F

3.7 Israel Antibody Discovery Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing investment in research and development of therapeutic antibodies in Israel

4.2.2 Growing prevalence of chronic diseases driving the demand for innovative antibody therapies

4.2.3 Technological advancements in antibody discovery methods and tools in the Israeli market

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for antibody development and commercialization in Israel

4.3.2 Limited availability of skilled professionals specialized in antibody discovery and development in the country

6.1 Israel Antibody Discovery Market, By Technology

6.1.1 Overview and Analysis

6.1.2 Israel Antibody Discovery Market Revenues & Volume, By Technology, 2021 - 2031F

6.1.3 Israel Antibody Discovery Market Revenues & Volume, By Hybridoma, 2021 - 2031F

6.1.4 Israel Antibody Discovery Market Revenues & Volume, By Phage Display, 2021 - 2031F

6.1.5 Israel Antibody Discovery Market Revenues & Volume, By Single-Cell Screening, 2021 - 2031F

6.2 Israel Antibody Discovery Market, By End User

6.2.1 Overview and Analysis

6.2.2 Israel Antibody Discovery Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F

6.2.3 Israel Antibody Discovery Market Revenues & Volume, By Academic Institutes, 2021 - 2031F

6.2.4 Israel Antibody Discovery Market Revenues & Volume, By CROs, 2021 - 2031F

6.3 Israel Antibody Discovery Market, By Therapeutic Area

6.3.1 Overview and Analysis

6.3.2 Israel Antibody Discovery Market Revenues & Volume, By Oncology, 2021 - 2031F

6.3.3 Israel Antibody Discovery Market Revenues & Volume, By Autoimmune Diseases, 2021 - 2031F

6.3.4 Israel Antibody Discovery Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F

7.1 Israel Antibody Discovery Market Export to Major Countries

7.2 Israel Antibody Discovery Market Imports from Major Countries

8.1 Number of research grants allocated to antibody discovery projects in Israel

8.2 Number of patents filed for novel antibody technologies in Israel

8.3 Percentage increase in collaboration agreements between Israeli biotech companies and global pharmaceutical firms in the field of antibody discovery.

9.1 Israel Antibody Discovery Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 Israel Antibody Discovery Market Opportunity Assessment, By End User, 2021 & 2031F

9.3 Israel Antibody Discovery Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F

10.1 Israel Antibody Discovery Market Revenue Share, By Companies, 2024

10.2 Israel Antibody Discovery Market Competitive Benchmarking, By Operating and Technical Parameters